View in EDS

Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre.

Saved in:
Bibliographic Details
Title: Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre.
Authors: Mosteiro M; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Azuara D; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain., Villatoro S; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain., Alay A; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Gausachs M; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Varela M; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain., Baixeras N; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain., Pijuan L; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain., Ajenjo-Bauza M; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Lopez-Doriga A; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain., Teulé Á; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain., Solanes A; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain., Palmero R; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Brenes J; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Jové M; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Padrones S; Department of Respiratory Medicine, Hospital Universitari de Bellvitge, L'Hospitalet del Llobregat, Barcelona, Spain., Moreno V; Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain; Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona, Barcelona, Spain., Cordero D; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain. Electronic address: dcordero@iconcologia.net., Matías-Guiu X; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain. Electronic address: xmatias@bellvitgehospital.cat., Lázaro C; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Electronic address: conxi.lazaro@gmail.com., Nadal E; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: esnadal@iconcologia.net.
Source: ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102197. Date of Electronic Publication: 2023 Dec 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38070435
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mosteiro+M%22">Mosteiro M</searchLink>; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Azuara+D%22">Azuara D</searchLink>; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villatoro+S%22">Villatoro S</searchLink>; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alay+A%22">Alay A</searchLink>; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gausachs+M%22">Gausachs M</searchLink>; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Varela+M%22">Varela M</searchLink>; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Baixeras+N%22">Baixeras N</searchLink>; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pijuan+L%22">Pijuan L</searchLink>; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ajenjo-Bauza+M%22">Ajenjo-Bauza M</searchLink>; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lopez-Doriga+A%22">Lopez-Doriga A</searchLink>; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Teulé+Á%22">Teulé Á</searchLink>; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Solanes+A%22">Solanes A</searchLink>; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Palmero+R%22">Palmero R</searchLink>; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Brenes+J%22">Brenes J</searchLink>; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Jové+M%22">Jové M</searchLink>; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Padrones+S%22">Padrones S</searchLink>; Department of Respiratory Medicine, Hospital Universitari de Bellvitge, L'Hospitalet del Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moreno+V%22">Moreno V</searchLink>; Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain; Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cordero+D%22">Cordero D</searchLink>; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain. Electronic address: dcordero@iconcologia.net.<br /><searchLink fieldCode="AU" term="%22Matías-Guiu+X%22">Matías-Guiu X</searchLink>; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain. Electronic address: xmatias@bellvitgehospital.cat.<br /><searchLink fieldCode="AU" term="%22Lázaro+C%22">Lázaro C</searchLink>; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Electronic address: conxi.lazaro@gmail.com.<br /><searchLink fieldCode="AU" term="%22Nadal+E%22">Nadal E</searchLink>; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: esnadal@iconcologia.net.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102197. <i>Date of Electronic Publication: </i>2023 Dec 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38070435
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2023.102197
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102197
    Titles:
      – TitleFull: Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mosteiro M
      – PersonEntity:
          Name:
            NameFull: Azuara D
      – PersonEntity:
          Name:
            NameFull: Villatoro S
      – PersonEntity:
          Name:
            NameFull: Alay A
      – PersonEntity:
          Name:
            NameFull: Gausachs M
      – PersonEntity:
          Name:
            NameFull: Varela M
      – PersonEntity:
          Name:
            NameFull: Baixeras N
      – PersonEntity:
          Name:
            NameFull: Pijuan L
      – PersonEntity:
          Name:
            NameFull: Ajenjo-Bauza M
      – PersonEntity:
          Name:
            NameFull: Lopez-Doriga A
      – PersonEntity:
          Name:
            NameFull: Teulé Á
      – PersonEntity:
          Name:
            NameFull: Solanes A
      – PersonEntity:
          Name:
            NameFull: Palmero R
      – PersonEntity:
          Name:
            NameFull: Brenes J
      – PersonEntity:
          Name:
            NameFull: Jové M
      – PersonEntity:
          Name:
            NameFull: Padrones S
      – PersonEntity:
          Name:
            NameFull: Moreno V
      – PersonEntity:
          Name:
            NameFull: Cordero D
      – PersonEntity:
          Name:
            NameFull: Matías-Guiu X
      – PersonEntity:
          Name:
            NameFull: Lázaro C
      – PersonEntity:
          Name:
            NameFull: Nadal E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1